Acquired deficiency of prothrombin complex coagulation factors in major bleeding is a therapeutic indication of 4-factor prothrombin complex concentrates

Wiedermann Christian J.

首页> 外文期刊>Transfusion medicine >Acquired deficiency of prothrombin complex coagulation factors in major bleeding is a therapeutic indication of 4-factor prothrombin complex concentrates

【24h】

Acquired deficiency of prothrombin complex coagulation factors in major bleeding is a therapeutic indication of 4-factor prothrombin complex concentrates

机译：在重大出血中获得的凝血酶原凝血因子的缺乏是4因素凝血酶体复合物浓缩物的治疗指示

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Transfusion medicine 》 |2020年第6期| 共1页
作者
Wiedermann Christian J.;
展开▼
作者单位

Univ Hlth Sci Med Informat &

Technol Inst Publ Hlth Med Decis Making &

HTA Eduard Wallnofer Pl 1;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Reversal of Warfarin-Associated Major Hemorrhage: Activated Prothrombin Complex Concentrate versus 4-Factor Prothrombin Complex Concentrate [J] . Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 2020 ,第2期

机译：逆转华法林相关主要出血：活化凝血酶原浓缩浓缩物与4系子凝血酶体复合物浓缩物
2. Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa [J] . Barton Cassie A., Hom Marissa, Johnson Nathan B., The American Journal of Surgery . 2018 ,第5期

机译：具有4因素凝血酶原浓缩物与重组因子viia的4系凝血酶体复合物浓缩物的协议的华法林逆转，与三因素凝血酶原浓缩物
3. Discussion of "Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa" [J] . Van Dusen Rachel The American Journal of Surgery . 2018 ,第5期

机译：“用4因数凝血酶浓缩物与三因素凝血酶浓缩物与重组因子viia的三因素凝血酶浓缩物的探讨”
4. IMMUNATE S/D - A new Factor VIII - von-Willebrand Factor Complex Concentrate [C] . P.L. Turecek, W. Schonhofer, T.R. Kreil, Hemophilie-Symposion . 2004

机译：免疫S / D - 一种新因子VIII - von-Willebrand系数复合浓缩物
5. Reversal of Warfarin-Associated Coagulopathy: Prothrombin Complex Concentrates Versus Fresh Frozen Plasma in Elderly Patients Presenting with Intracranial Hemorrhage [D] . Lumas, Shunella Grace. 2020

机译：逆转华法林相关凝血病：凝血酶原浓缩物与颅内出血患者的老年患者新鲜冷冻血浆
6. Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding A Randomized Plasma-Controlled Phase IIIb Study [O] . Ravi Sarode, Truman J. Milling Jr, Majed A. Refaai, -1

机译：4-因子凝血酶原复合物浓缩物对主要出血患者的维生素K拮抗剂的有效性和安全性随机对照血浆IIIb期研究
7. 64 Health Care Costs in Direct-acting Oral Anticoagulant Major Bleeding Treated with 4-factor Prothrombin Complex Concentrate and Other Agents [O] . A.J. Singer, C.E. Mahan, K. McNeil-Posey, 2020

机译：64种医疗保健成本直接服用口服抗凝血剂重型出血，用4因素凝血酶浓缩物和其他药剂治疗
8. Prolonged Prothrombin Time After Recombinant Activated Factor VII Therapy in Critically Bleeding Trauma Patients Is Associated With Adverse Outcomes. [R] . McMullin, N. R., Wade, C. E., Holcomb, J. B., 2010

机译：重组活化因子VII治疗后严重出血创伤患者的凝血酶原时间延长与不良后果相关。

Acquired deficiency of prothrombin complex coagulation factors in major bleeding is a therapeutic indication of 4-factor prothrombin complex concentrates

著录项

相似文献

相关主题

期刊订阅